Chemoinformaics analysis of Ethyl tetradecanoate
| Molecular Weight | 256.43 | nRot | 13 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 3 |
| Exact Molecular Weight | 256.24 | nRing | 0 |
| Solubility: LogS | -2.326 | nHRing | 0 |
| Solubility: LogP | 2.842 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 49.6614 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.325 |
| Synth | 3.002 |
| Natural Product Likeliness | 2.303 |
| NR-PPAR-gamma | 0.525 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.004 |
| CACO-2 | -4.401 |
| MDCK | 0.0000216 |
| BBB | 0.991 |
| PPB | 0.398481 |
| VDSS | 1.292 |
| FU | 0.459459 |
| CYP1A2-inh | 0.357 |
| CYP1A2-sub | 0.285 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.179 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.465 |
| CYP3a4-inh | 0.122 |
| CYP3a4-sub | 0.123 |
| CL | 10.813 |
| T12 | 0.725 |
| hERG | 0.014 |
| Ames | 0.915 |
| ROA | 0.008 |
| SkinSen | 0.978 |
| Carcinogencity | 0.2 |
| EI | 0.995 |
| Respiratory | 0.909 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.706324 |